News brief
On 2026-08-21, according to Xiniu Data, Panpuluona completed Pre-Series A financing for an undisclosed amount. Investors were Hubei Changjiangketouyuanchuangliqingyuanlian Venture Capital Partnership (Limited Partnership). The company is an AI-driven developer of innovative targeted protein degradation drugs.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年8月21日，据烯牛数据报道，潘普洛纳完成Pre-A轮融资，金额未披露。投资方为湖北长江科投源创力清源离岸创业投资合伙企业（有限合伙）。该公司为AI驱动靶向蛋白降解创新药研发商。